Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution-Reference-Cited by-同舟云学术

Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution

Published:2018-05-31 Issue:12 Volume:26 Page:4097-4103
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Bacrie Joy^ORCID,Laurans Marc,Iorio Pauline,Fourme Emmanuelle,Volters Anne Béthune,Bozec Laurence,Lerebours Florence,Dubot Coraline,Bensaoula Okba,Benzidane Bilel,Pierga Jean-Yves,Lefeuvre Delphine

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-018-4280-4/fulltext.html

Reference24 articles.

1. Les cancers en France, édition2016, INCa 2017, http://www.e-cancer.fr/ressources/cancers_en_france/#page=13

2. Kuderer NM (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106:2258–2266

3. Lyman GH, Rolston (2010) How we treat febrile neutropenia in patients receiving cancer chemotherapy. J Oncol Pract 6(3):149–152

4. Kosaka Y (2015) Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Support Care Cancer 23(4):1137–1143

5. Smith TJ et al (2006) Update recommendations for the use of white blood cell growth factors: an evidence based clinical practice guideline. J Clinic Oncol 24(19):3187–3205

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Verification on the Predictors for Febrile Neutropenia in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy;Anticancer Research;2022-12-30

2. Management of chemotherapy-induced febrile neutropenia and use of granulocyte colony-stimulating factor in patients with soft tissue or bone sarcoma;Journal of Oncology Pharmacy Practice;2022-10-13

3. Real-world evaluation of supportive care using an electronic health record text-mining tool: G-CSF use in breast cancer patients;Supportive Care in Cancer;2022-08-31

4. Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study;Frontiers in Oncology;2022-04-25

5. BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High–Neutropenia Risk Chemotherapy;Journal of the National Comprehensive Cancer Network;2021-08-16